Brain cancer recurrence presents a significant challenge for patients, particularly in the context of pediatric gliomas, which can be both devastating and difficult to predict.Recent advancements in AI prediction for brain cancer have shown promise, with cutting-edge tools surpassing traditional methods in assessing cancer relapse risk.